Olympus Recognized for Sustainability Leadership in Dow Jones Index

We are pleased to announce that Olympus Corporation has been named to the Dow Jones Sustainability World Index (DJSI World) for the fourth consecutive year. This recognition highlights Olympus' commitment to sustainability and responsible business practices, making it a standout performer in the Health Care Equipment & Supplies sector.

Our analysis of Olympus' sustainability performance:

1. Climate Strategy: Olympus has been recognized for its ambitious climate goals, approved by the Science Based Targets initiative (SBTi). The company has committed to reducing absolute scope 1 and 2 GHG emissions by 70% by FY2031 from a FY2020 base year. Additionally, Olympus aims to have 80% of its suppliers by emissions, covering purchased goods and services, capital goods, and upstream transportation and distribution, adopt science-based targets by FY2028. Furthermore, Olympus has set a net-zero GHG emissions target across its value chain by 2040. These targets demonstrate Olympus' dedication to combating climate change and reducing its environmental footprint.
2. Materiality: Olympus has been praised for its appropriate target setting and policy management aimed at resolving important issues. The company has made changes to its management structure to take a proactive approach to ESG goals and strengthen its efforts to address materiality. This commitment has contributed to Olympus' improved score in the "Materiality" category and its fourth consecutive selection to the DJSI World.

What's Happening in the Health Care Equipment & Supplies Sector:

Medtronic invests $1 billion in AI and machine learning. The medical device giant is expanding its digital health portfolio with a $1 billion investment in AI and machine learning technologies. The company aims to develop new products and services that improve patient outcomes and enhance the efficiency of healthcare systems.

Stryker acquires Ortho Clinical Diagnostics for $5.3 billion. The medical technology company has acquired Ortho Clinical Diagnostics, a global leader in in vitro diagnostics, to expand its portfolio and strengthen its position in the diagnostics market. The acquisition is expected to generate synergies and drive growth for Stryker.



#
In conclusion, Olympus' recognition in the DJSI World for the fourth consecutive year is a testament to the company's commitment to sustainability and responsible business practices. Its ambitious climate goals and proactive approach to addressing materiality have positioned Olympus as a leader in the Health Care Equipment & Supplies sector. As investors, we should consider companies like Olympus that prioritize sustainability and ESG initiatives, as they are more likely to create long-term value and contribute to a sustainable future.